Related Experiment Video
Updated: Jun 8, 2026

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
Microalbuminuria is not a valuable marker for relapse in Crohn's disease
C S Horjus1, M G H van Oijen, A H Davids
1Department of Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Insights
Microalbuminuria was moderately common in patients with quiescent Crohn's disease (CD). However, this study found no significant association between microalbuminuria and disease activity or predicting relapses in CD patients.
Area of Science:
- Gastroenterology
- Nephrology
- Clinical Medicine
Background:
- Previous studies suggested a link between microalbuminuria and disease activity in Crohn's disease (CD).
- The current research aimed to evaluate microalbuminuria's potential as a relapse marker in quiescent CD.
Purpose of the Study:
- To determine if microalbuminuria predicts relapses in patients with quiescent Crohn's disease.
- To assess the association between microalbuminuria and disease characteristics in CD.
Main Methods:
- A 1-year prospective trial involving 139 patients with quiescent CD on oral budesonide.
- Microalbuminuria was measured at baseline and throughout the follow-up period, including at relapse.
- Statistical analysis included logistic regression and time-dependent Cox regression.
Main Results:
- Microalbuminuria was present in 8 patients at randomization and in 11% of those who relapsed.
- No statistically significant association was found between microalbuminuria and relapse (OR 0.92, 95% CI 0.76-1.13).
- Time-dependent Cox regression also showed no predictive value for microalbuminuria (HR 1.29, 95% CI 0.37-4.39).
Conclusions:
- Microalbuminuria showed moderate prevalence in quiescent CD patients.
- It was not associated with disease characteristics or pre-randomization medication.
- Microalbuminuria did not prove to be a reliable predictor of relapses in this cohort.
Background:
Previous reports correlated microalbuminuria with disease activity in patients with Crohn's disease (CD). The aim of the present study is to determine the value of microalbuminuria as a marker for relapses in quiescent CD.
Methods:
In a 1-year prospective maintenance trial with oral budesonide in patients with CD in remission, microalbuminuria was measured at randomization, after 2, 6 and 12 months, plus at the time of a relapse. The association of microalbuminuria with the course of disease was analyzed with logistic regression analysis. Time-dependent Cox regression was undertaken to study the association between microalbuminuria and relapse.
Results:
We included a total of 139 patients. At randomization, microalbuminuria was present in 8 patients. During a 1-year follow-up, 29 patients relapsed and in 11% (3/29), microalbuminuria was present during the relapse. We found no statistically significant association between microalbuminuria and relapse (odds ratio 0.92, 95% confidence interval (CI) 0.76-1.13). Time-dependent Cox regression analysis also revealed no statistical predictive value for microalbuminuria (hazard ratio 1.29, 95% CI 0.37-4.39, p = 0.68).
Conclusion:
Microalbuminuria was moderately prevalent in quiescent CD patients, but it could not be associated with disease characteristics or the type of medication before randomization, nor as a predictor for relapses.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Diabetic Nephropathy
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome II : Assessment and Medical Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

